Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis

Published:2012-10-31 Issue:1 Volume:7 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Shirata Yuko,Jingu Keiichi,Koto Masashi,Kubozono Masaki,Takeda Ken,Sugawara Toshiyuki,Kadoya Noriyuki,Matsushita Haruo

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-7-182.pdf

Reference26 articles.

1. Buyyounouski MK, Balter P, Lewis B, et al.: Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO emerging technology committee. Int J Radiat Oncol Biol Phys 2010, 78: 3-10. 10.1016/j.ijrobp.2010.04.010

2. Onimaru R, Fujino M, Yamazaki K, et al.: Steep dose–response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70: 374-381. 10.1016/j.ijrobp.2007.06.043

3. Onishi H, Shirato H, Nagata Y, et al.: Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2: S94-S100. 10.1097/JTO.0b013e318074de34

4. Asamura H, Goya T, Koshiishi Y, et al.: A Japanese Lung Cancer Registry Study: Prognosis of 13010 Resected Lung Cancers. J Thorac Oncol 2007, 3: 46-52.

5. Willard AF, Jerri LP, Herman RM: Ten-year survey of lung cancer treatment and survival in hospitals in the United States. A national cancer data base report. Cancer 1999,86(9):1867-1876. 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose–effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients;Radiation Oncology;2022-12-23

2. Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis;Cancers;2022-08-05

3. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis;Annals of Translational Medicine;2022-01

4. Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy;Physica Medica;2021-08

5. Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3